Mandy Fechner

437 total citations
10 papers, 361 citations indexed

About

Mandy Fechner is a scholar working on Molecular Biology, Biochemistry and Pathology and Forensic Medicine. According to data from OpenAlex, Mandy Fechner has authored 10 papers receiving a total of 361 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 3 papers in Biochemistry and 2 papers in Pathology and Forensic Medicine. Recurrent topics in Mandy Fechner's work include Ubiquitin and proteasome pathways (4 papers), Eicosanoids and Hypertension Pharmacology (3 papers) and Liver Disease and Transplantation (2 papers). Mandy Fechner is often cited by papers focused on Ubiquitin and proteasome pathways (4 papers), Eicosanoids and Hypertension Pharmacology (3 papers) and Liver Disease and Transplantation (2 papers). Mandy Fechner collaborates with scholars based in Germany, China and United States. Mandy Fechner's co-authors include Verena Stangl, Gert Baumann, Karl Stangl, Silke Meiners, Henryk Dreger, Antje Ludwig, Wolf‐Hagen Schunck, Duska Dragun, Uwe Hoff and Nicola Wilck and has published in prestigious journals such as PLoS ONE, International Journal of Molecular Sciences and Hypertension.

In The Last Decade

Mandy Fechner

10 papers receiving 356 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mandy Fechner Germany 10 155 50 47 43 41 10 361
Kyung Ae Lee South Korea 14 173 1.1× 20 0.4× 45 1.0× 45 1.0× 75 1.8× 52 616
Ana M. Rodrı́guez-López Spain 11 159 1.0× 55 1.1× 34 0.7× 35 0.8× 53 1.3× 21 380
Tongfeng Zhao China 13 187 1.2× 21 0.4× 61 1.3× 60 1.4× 22 0.5× 25 383
Shanhong Lu China 13 254 1.6× 60 1.2× 37 0.8× 93 2.2× 58 1.4× 24 647
Jingjing Wu China 14 309 2.0× 23 0.5× 55 1.2× 35 0.8× 55 1.3× 27 535
Taishan Zheng China 14 344 2.2× 37 0.7× 61 1.3× 59 1.4× 50 1.2× 32 662
Phyllis Chew Australia 8 165 1.1× 56 1.1× 56 1.2× 74 1.7× 11 0.3× 9 541
Wensong Zhang China 10 228 1.5× 17 0.3× 51 1.1× 19 0.4× 23 0.6× 22 461
Ainhoa Oguiza Spain 11 212 1.4× 70 1.4× 61 1.3× 25 0.6× 92 2.2× 13 507
Jun Honjo Japan 12 240 1.5× 115 2.3× 61 1.3× 60 1.4× 49 1.2× 19 634

Countries citing papers authored by Mandy Fechner

Since Specialization
Citations

This map shows the geographic impact of Mandy Fechner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mandy Fechner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mandy Fechner more than expected).

Fields of papers citing papers by Mandy Fechner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mandy Fechner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mandy Fechner. The network helps show where Mandy Fechner may publish in the future.

Co-authorship network of co-authors of Mandy Fechner

This figure shows the co-authorship network connecting the top 25 collaborators of Mandy Fechner. A scholar is included among the top collaborators of Mandy Fechner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mandy Fechner. Mandy Fechner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Hoff, Uwe, Mandy Fechner, Ye Zhu, et al.. (2019). A synthetic epoxyeicosatrienoic acid analogue prevents the initiation of ischemic acute kidney injury. Acta Physiologica. 227(2). e13297–e13297. 22 indexed citations
2.
Wilck, Nicola, et al.. (2017). The Effect of Low-Dose Proteasome Inhibition on Pre-Existing Atherosclerosis in LDL Receptor-Deficient Mice. International Journal of Molecular Sciences. 18(4). 781–781. 11 indexed citations
3.
Zhu, Ye, Uwe Hoff, Mandy Fechner, et al.. (2016). Renal Ischemia/Reperfusion Injury in Soluble Epoxide Hydrolase-Deficient Mice. PLoS ONE. 11(1). e0145645–e0145645. 23 indexed citations
4.
Pohlmann, Andreas, Jan Hentschel, Mandy Fechner, et al.. (2013). High Temporal Resolution Parametric MRI Monitoring of the Initial Ischemia/Reperfusion Phase in Experimental Acute Kidney Injury. PLoS ONE. 8(2). e57411–e57411. 54 indexed citations
5.
Hoff, Uwe, Mandy Fechner, Ruth Schmidt‐Ullrich, et al.. (2013). Novel signalling mechanisms and targets in renal ischaemia and reperfusion injury. Acta Physiologica. 208(1). 25–40. 55 indexed citations
6.
Lorenz, Mario, Mandy Fechner, Kati Fröhlich, et al.. (2012). Effects of Lycopene on the Initial State of Atherosclerosis in New Zealand White (NZW) Rabbits. PLoS ONE. 7(1). e30808–e30808. 38 indexed citations
7.
Wilck, Nicola, Mandy Fechner, Henryk Dreger, et al.. (2012). Attenuation of Early Atherogenesis in Low-Density Lipoprotein Receptor–Deficient Mice by Proteasome Inhibition. Arteriosclerosis Thrombosis and Vascular Biology. 32(6). 1418–1426. 25 indexed citations
8.
Ludwig, Antje, Mandy Fechner, Nicola Wilck, et al.. (2009). Potent anti-inflammatory effects of low-dose proteasome inhibition in the vascular system. Journal of Molecular Medicine. 87(8). 793–802. 33 indexed citations
9.
Meiners, Silke, Henryk Dreger, Mandy Fechner, et al.. (2007). Suppression of Cardiomyocyte Hypertrophy by Inhibition of the Ubiquitin-Proteasome System. Hypertension. 51(2). 302–308. 87 indexed citations
10.
Pechan, Paul, W. A. Keller, Mandy Fechner, & M. Bergeron. (1988). Selection of Brassica napus L. embryogenic microspores by flow sorting. Plant Cell Reports. 7(6). 396–398. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026